The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence of detectable HBV DNA in cancer patients with resolved HBV infection (HBsAg (-) HBcAb (+) and its evolution after cytotoxic chemotherapy.
Taral Ramesh Shah
No relevant relationships to disclose
Huo Xiang Zheng
No relevant relationships to disclose
Pouyan Gohari
No relevant relationships to disclose
Maxim Shulimovich
No relevant relationships to disclose
Yiwu Huang
No relevant relationships to disclose
Yiqing Xu
No relevant relationships to disclose